Advertisement

Topics

Rodman & Renshaw, LLC Company Profile

06:35 EDT 21st September 2017 | BioPortfolio

Rodman & Renshaw Capital Group, Inc. (NASDAQ: RODM) is a holding company with a number of direct and indirect subsidiaries, including Rodman & Renshaw, LLC.


News Articles [195 Associated News Articles listed on BioPortfolio]

Ampio Pharmaceuticals, Inc. to Present at the 19th Annual Rodman Renshaw Global Investment ...

Event: 19 thAnnual Rodman & Renshaw Global Investment Conference Date: September 12, 2017 Time: 11:15-11:40 pm (Eastern Time) Location: Lotte New York Palace About Read more...

Soligenix to Present at the Rodman Renshaw 19th Annual Global Investment Conference in New York City

To access an audio webcast of the Soligenix corporate presentation, please click here.  For more information about the Rodman & Renshaw Global Investment Conference, Read more...

Eleven Biotherapeutics to Present at the Rodman & Renshaw 19th Annual Global Investment Conference

Tuesday, September 5th 2017 at 12:00pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Eleven Biotherapeutics, Inc. (NASDAQ:EBIO), a late-stage clinical oncology company advancing a broad pipeline o...

AmpliPhi Biosciences to Present at Rodman & Renshaw 19th Annual Global Investment Conference

Tuesday, September 5th 2017 at 10:50am UTC SAN DIEGO–(BUSINESS WIRE)– AmpliPhi Biosciences Corporation (NYSE American: APHB), a clinical-stage biotechnology company focused on the developm...

Valeant Pharmaceuticals-Aktie: ist das Ende des Anfangs gekommen? - Aktienanalyse

New York - Valeant Pharmaceuticals-Aktienanalyse von Analyst Raghuram Selvaraju von Rodman & Renshaw: Raghuram Selvaraju, Aktienanalyst vom Investmenthaus Rodman & Renshaw, vertritt laut einer Akti...

Plug Power-Aktie: neue Zusammenarbeit mit Wal-Mart! - Aktienanalyse

New York - Plug Power-Aktienanalyse von Analyst Amit Dayal von Rodman & Renshaw: Laut einer Aktienanalyse empfiehlt Analyst Amit Dayal vom Investmenthaus Rodman & Renshaw die Aktien des Brennstoffz...

DGAP-News: Pharnext präsentiert auf der Rodman & Renshaw 19th Annual Global Investment Conference (deutsch)

Pharnext präsentiert auf der Rodman & Renshaw 19th Annual Global Investment Conference DGAP-News: Pharnext S.A. / Schlagwort(e): Konferenz Pharnext präsentiert auf der Rodman & Renshaw 19th Annual.....

Rodman & Renshaw’s 19th Annual Global Investment Conference to Be Held September 10th to 12th in New York City

Rodman & Renshaw’s 19th Annual Global Investment Conference, sponsored by H.C. Wainwright & Co., will be held September 10th through 12th, 2017 at the Lotte New York Pal...

Drugs and Medications [0 Results]

None

PubMed Articles [2 Associated PubMed Articles listed on BioPortfolio]

Right- Sided InterStim Placement in a Patient with Left Sacral Hypoplasia.

Sacral hypoplasia is a rare anomaly and the least severe pattern of caudal regression syndrome as described by the Renshaw classification system. These patients may suffer from bladder and/or bowel dy...

Descending systems direct development of key spinal motor circuits Abbreviated title: Postnatal development of spinal motor circuits.

The formation of mature spinal motor circuits is dependent on both activity dependent and independent mechanisms during postnatal development. During this time, reorganisation and refinement of spinal...

Clinical Trials [0 Results]

None

Companies [9 Associated Companies listed on BioPortfolio]

Rodman & Renshaw, LLC

Rodman & Renshaw Capital Group, Inc. (NASDAQ: RODM) is a holding company with a number of direct and indirect subsidiaries, including Rodman & Renshaw, LLC.

Rodman & Renshaw, LLC Rodman & Renshaw, LLC and Cowen and Company acts as Exclusive Co-Placement Agents to Access Pharmaceuticals, Inc. in the Private Placement of $5.2 Million

Rodman & Renshaw Capital Group, Inc.

Rodman & Renshaw, a unit of H.C. Wainwright & Co., LLC is an investment bank dedicated to providing corporate finance, strategic advisory, research, sales and trading, and other r...

Rodman & Renshaw Conferences, LLC

Advaxis, Inc. and Rodman & Renshaw, LLC

Advaxis is a biotechnology company developing the next generation of immunotherapies for cancer and infectious diseases. Advaxis immunotherapies are based on a novel platform tech...

More Information about "Rodman & Renshaw, LLC" on BioPortfolio

We have published hundreds of Rodman & Renshaw, LLC news stories on BioPortfolio along with dozens of Rodman & Renshaw, LLC Clinical Trials and PubMed Articles about Rodman & Renshaw, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Rodman & Renshaw, LLC Companies in our database. You can also find out about relevant Rodman & Renshaw, LLC Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record